Table 2.
*Medication | No of participants |
---|---|
Glucose-lowering drugs | 18 |
Metformin | 16 |
Thiazolidinedione | 7 |
Sulfonamides | 2 |
Anti-depressants | 8 |
Benzodiazepine | 1 |
Selective serotonin reuptake inhibitors | 4 |
Serotonin-norepinephrine reuptake inhibitors |
1 |
Aminoketones | 2 |
Anti-hypertensive drugs | 16 |
Angiotensin converting enzyme inhibitors | 8 |
Hydrochlorothiazides | 4 |
Angiotensin receptor blocker | 5 |
Lipid-lowering drugs | 16 |
HMG-CoA reductase inhibitors | 15 |
Fibrate | 1 |
Some participants received more than one medication and may therefore be counted in more than one categories